|
|
Post by sellhighdrinklow on Aug 28, 2020 11:03:23 GMT -5
|
|
|
|
Post by peppy on Aug 28, 2020 12:41:23 GMT -5
in the dreamboat, it could "areo nab" all the way to the alveoli. Researchers from Synairgen revealed a few weeks ago that a nebulizer that delivers interferon-beta aerosols directly into the lungs of infected COVID-19 patients could significantly improve their condition. That seemed to be the kind of breakthrough treatment the world could benefit from in the coming years until vaccines become widely available. What the researchers created is a different type of monoclonal antibody therapy. But rather than using regular-size antibodies, the researchers went for smaller “nanobodies” that are crafted to block the coronavirus infection the same way other neutralizing antibodies would. The nanobodies hook up to the spike protein that’s found at the exterior of the coronavirus capsule, rendering it useless. That way, the virus can’t bind to ACE2 receptors found on various cells, including cells inside the lung. Entering cells is a key process for any virus, as that’s what allows it to replicate and then continue to infect other cells. It turns out other researchers have been thinking of deploying antiviral drugs via inhalers, directly into the airways of patients. The University of California San Francisco (UCSF) created a nasal spray made of a particular type of neutralizing-antibody-like proteins that can block the virus from infecting cells. This, too, could be the kind of drug the world needs right now. But AeroNabs still needs clinical testing to prove it can do what the researchers say it does. While a paper explaining the science behind AeroNabs exists, the drug has not been tested in clinical trials on humans, and there’s no telling whether it’ll ever reach that stage. “ Used once a day, AeroNabs could provide powerful, reliable protection against SARS-CoV-2 until a vaccine becomes available,” a UCSF news release reads. The team of researchers published their findings in pre-print version in bioRxiv, and they’re in active discussions with commercial partners to ramp up manufacturing of the AeroNabs sprays and start clinical testing. bgr.com/2020/08/12/coronavirus-cure-aeronabs-nanobodies-inhaler-ucsf/Synthetic protein. |
|
|
|
Post by goyocafe on Aug 28, 2020 12:49:13 GMT -5
I doubt we'll ever know if MNKD is involved in any discussions with any of these institutions until it is announced formally, and that's only if something works out. I just hope MC really isn't waiting for them to knock on his door.
|
|
|
|
Post by falconquest on Sept 1, 2020 18:23:01 GMT -5
I doubt we'll ever know if MNKD is involved in any discussions with any of these institutions until it is announced formally, and that's only if something works out. I just hope MC really isn't waiting for them to knock on his door. Yeah, let's hope he doesn't fall into "call me" mode! |
|
